Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06387940
Other study ID # UEC 2019 008 FHMS
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 5, 2019
Est. completion date November 20, 2022

Study information

Verified date April 2024
Source University of Surrey
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigates how different low-carbohydrate diets affect metabolism and hunger in overweight adults. We will measure metabolic rates and blood metabolites.


Description:

Participants will engage in three distinct eating plans: a standard diet with usual carbohydrate and calorie levels, a low-carb diet with typical calories, and a low-carb diet with reduced calories. Each diet is followed for a single day, with subsequent monitoring to assess how the body processes food and manages hunger after a meal. The goal is to understand the potential metabolic benefits of reducing carbohydrate intake, either alone or in combination with calorie reduction. This research aims to identify simpler dietary strategies that could improve heart health and assist in weight management without the need for severe calorie restriction or fasting, offering valuable insights for enhancing health outcomes in overweight individuals.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date November 20, 2022
Est. primary completion date April 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria: - stable weight within ±3 kg over the past three months - no significant medical history. Exclusion Criteria: - pregnancy - breastfeeding, - using medications that could affect the study's outcomes - high intake of caffeine and alcohol - existing eating or psychiatric disorders - adherence to strict dietary regimens like veganism - high BMI resulting from significant muscle mass

Study Design


Related Conditions & MeSH terms


Intervention

Other:
nEB Diet, followed for 36 hours
nEB diet first, then LC25 and LCEB in random order with a 5 days washout between each diet
LC25 Diet, followed for 36 hours
LC25 diet first, then nEB and LCEB in random order with a 5 days washout between each diet
LCEB Diet, followed for 36 hours
LCEB diet first, then LC25 and nEB in random order with a 5 days washout between each diet

Locations

Country Name City State
United Kingdom University of Surrey Guildford

Sponsors (1)

Lead Sponsor Collaborator
University of Surrey

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Biomarkers in blood Measured Measured with ELISA assay and clinical analyser (INDIKO) 8 hours (fasting and post-meal)
Primary Resting metabolic rate Measured with indirect calorimetry (GEM) 8 hours (fasting and post-meal)
Secondary Perceived Appetite Scores Measured with a Visual Analog Scale 8 hours (fasting and post-meal)
Secondary Food intake Measured using food diaries baseline and after each diet arm for 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1